Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly's boss calls UK the 'worst' European country for drug prices
04:12am, Wednesday, 24'th Sep 2025
Eli Lilly Chief Executive Dave Ricks said Britain was "probably the worst country in Europe" for drug prices in an interview with the Financial Times, intensifying pressure on the government to improv
Eli Lilly (LLY) Falls More Steeply Than Broader Market: What Investors Need to Know
06:46pm, Tuesday, 23'rd Sep 2025
In the closing of the recent trading day, Eli Lilly (LLY) stood at $746.98, denoting a -1.06% move from the preceding trading day.
Eli Lilly to Build $6.5 Billion Ingredient-Manufacturing Facility in Texas
01:31pm, Tuesday, 23'rd Sep 2025
The planned site, which will be used to manufacture the company's first oral weight-loss drug, is expected to be operational within five years.
Eli Lilly to make weight-loss pill in new $6.5 billion Texas plant
01:03pm, Tuesday, 23'rd Sep 2025
Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar manufacturing plant it plans to build in Texas, the company said on Tuesday.
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
01:00pm, Tuesday, 23'rd Sep 2025
Eli Lilly said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company's pipeline of small molecule drugs, including its closely watched expe
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas
01:00pm, Tuesday, 23'rd Sep 2025
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines Company plans to create 4,615 manufactu
Funding will strengthen Boys & Girls Clubs serving youth who live on or near federal and state designated Native lands through program support, leadership development and digital transformation Fundin
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows
09:32pm, Monday, 22'nd Sep 2025
Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC from Eli Lilly in the United States for $330 million.
Innovent's weight-loss drug highlights China challenge for Novo, Lilly
07:03pm, Monday, 22'nd Sep 2025
Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining tra
2 Magnificent S&P 500 Dividend Stocks Down 7% and 19% to Buy and Hold Forever
01:25pm, Saturday, 20'th Sep 2025
U.S. equities have been volatile this year, but have had a strong run. The S&P 500 index gained 17.3% over the last year through Sept.
3 Stocks Insiders Are Buying Non-Stop
10:00am, Friday, 19'th Sep 2025
Insider buying is one of the few market signals that does not hide behind algorithms or price targets.
This Unstoppable Healthcare Stock Just Made a Move in AI: Time to Buy?
09:00am, Friday, 19'th Sep 2025
Recent breakthroughs in artificial intelligence (AI) are producing tangible results, and not just in the tech industry, although companies in that sector tend to dominate the AI headlines. Even in hea
Where Will Eli Lilly Be in 3 Years?
08:15am, Friday, 19'th Sep 2025
Even with the pullback it has experienced this year, Eli Lilly (LLY 0.37%) has crushed the market over the past three years. The company's shares have more than doubled over this period, making it one
LLY's Orforglipron Tops NVO's Oral Pill in Diabetes Study: What's Next?
12:21pm, Thursday, 18'th Sep 2025
Eli Lilly's orforglipron beat NVO's Rybelsus in a 52-week diabetes study, showing stronger A1C and weight loss benefits.
Here's Why Novo Nordisk and Eli Lilly Could Still Be Absurdly Underrated Stocks to Buy Today
12:05pm, Thursday, 18'th Sep 2025
Two of the hottest healthcare stocks in recent years have been Novo Nordisk (NVO 6.10%) and Eli Lilly (LLY 0.46%). The former has risen by 400% in the past five years, while the latter is up 67%.
